Registered Charity No. 1088008.

 

 
Chairman's Report
 
 

 

Conference 2005

back to Programme

AndroFront.jpg (9764 bytes)

DIAGNOSTIC SIGNIFICANCE OF FREE SALIVARY TESTOSTERONE

Vertkin, W., Goncharov,N.P., Katsya,G.V. Dobracheva, A.D., Nizhnik, A.N. Koryakin, M.V. National Center of Endocrinology, Dm. Ulyanova Street, 11, 117036, Moscow, Russia,

and Ziemann, W. IBL-Hamburg, Germany (see poster)

Project Description Saliva has attracted the attention of researchers for many years, since salivary glands possess the very particular feature of passing (by passive filtration) some blood components, including free steroids, not bound with SHBG and albumin, through the membrane barrier into the salivary ducts. The introduction by IBL of a novel ultrasensitive LIA technology for direct determination of free testosterone in microvolumes of biological materials, including saliva, opens new possibilities in the assessment of androgenic status both in men and women. Aims of our study were: · Evaluation of diagnostic significance of LIA technology for determination of free testosterone in saliva, using different clinical models of androgenic status. · Analyzing possible correlation between free testosterone concentration in saliva and calculated free testosterone and total testosterone level in blood.

Materials and methods To evaluate the diagnostic significance of IBL technology of salivary free testosterone measurement we selected the following groups of volunteers, consisting of men and women: 1. Healthy male volunteers, age 21 - 50 (n=16). 2. Male patients different forms of androgen deficiency (total T < 10 nmol/l, normal range 11-35 nmol/l) (n=14). Mean concentrations of free testosterone in saliva of 16 healthy men in the morning (8:30-9:30) varied within the range 75-162 pg/ml (10, 90 percentiles), median 108 pg/ml. Individual and mean concentrations of salivary free testosterone and free testosterone in blood in healthy men practically match each other. In 14 men with androgen deficiency, aged 22-68 yrs, mean concentration of total testosterone in the blood was 6.7 nmol/l (1.2-10.8 nmol/l) (median and 10-90 percentiles). Coefficient of variation of free salivary testosterone concentration in men with androgen deficiency during the day was 31% (18-68%) and did not differ significantly from that of healthy men: 24 (11-45%). Significance was determined by Mann-Whitney test. We conclude that the direct determination of free testosterone in saliva is a more adequate instrument for establishing androgenic status in comparison with mathematical calculation, as in the latter case the calculated level of free testosterone in blood depends on correct measurement of two parameters: total testosterone, and SHBG.

Conclusion IBL LIA technology for salivary testosterone measurement gives a good reflection of the unbound testosterone in plasma. Since free fraction is thought to determine exposure to the tissues, salivary testosterone concentrations should give a better indication of biologically active steroid than total plasma levels, especially in conditions of altered SHBG-binding.